CSVAX | HFQRX | CSVAX / HFQRX | |
Total Expense Ratio | 1.20 | 0.70 | 171% |
Annual Report Gross Expense Ratio | 1.30 | 0.70 | 186% |
Fund Existence | 22 years | 9 years | - |
Gain YTD | 1.909 | 3.101 | 62% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 507M | 5.77B | 9% |
Annual Yield % from dividends | 2.20 | 7.88 | 28% |
Returns for 1 year | -3.73 | 8.12 | -46% |
Returns for 3 years | 8.77 | 15.34 | 57% |
Returns for 5 years | 30.60 | 64.55 | 47% |
Returns for 10 years | 18.02 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IRFAX | 8.12 | 0.19 | +2.40% |
Cohen & Steers International Realty A | |||
PRCOX | 53.17 | 0.93 | +1.78% |
T. Rowe Price U.S. Equity Research | |||
RIVHX | 16.82 | 0.26 | +1.57% |
American Funds International Vntg R-2E | |||
GTORX | 31.00 | 0.45 | +1.47% |
Goldman Sachs Technology Opps R6 | |||
NBRCX | 21.78 | 0.31 | +1.44% |
Neuberger Berman M/C Intrinsic Val C |